Related Experiment Videos
Modulation and function of intercellular adhesion molecule-1 (CD54) on human retinal pigment epithelial cells
S G Elner1, V M Elner, M A Pavilack
1Department of Ophthalmology, University of Michigan, Ann Arbor.
This study investigated whether retinal pigment epithelial (RPE) cells express a protein called intercellular adhesion molecule-1 (ICAM-1), which is known to help immune cells stick to other cells. The researchers found that RPE cells normally have low levels of ICAM-1, but when exposed to certain inflammatory signals like interferon-gamma, interleukin-1 beta, or tumor necrosis factor-alpha, ICAM-1 levels increased significantly. They also found that RPE cells with higher ICAM-1 levels bound more immune cells, especially neutrophils. Blocking ICAM-1 or the immune cell receptors reduced this binding. The study suggests that RPE ICAM-1 may help regulate immune cell access to the retina, which could be important in eye diseases where immune cells play a role in causing damage.
Area of Science:
- Ophthalmology and Visual Sciences
- Immunology and Inflammation
- Cell and Molecular Biology
Background:
The human retinal pigment epithelium (RPE) forms part of the blood-retina barrier and plays a key role in regulating interactions between circulating leukocytes and retinal tissues. Prior research has shown that RPE cells are capable of modulating immune responses. However, it was unclear whether RPE cells express intercellular adhesion molecule-1 (ICAM-1), a glycoprotein known to mediate leukocyte adhesion. No prior work had resolved the functional role of ICAM-1 on RPE in the context of inflammatory cytokines. This gap motivated the investigation of whether RPE cells express ICAM-1 and whether this expression is modulated by inflammatory signals. The study sought to determine if RPE ICAM-1 could be a functional receptor for leukocyte binding. No prior studies had directly tested the role of RPE ICAM-1 in leukocyte adherence. The research aimed to clarify the expression and function of ICAM-1 on RPE cells under both baseline and stimulated conditions. This work provides new insights into how RPE cells may regulate immune cell infiltration in ocular diseases.
Purpose Of The Study:
The study aimed to investigate whether human retinal pigment epithelial (RPE) cells express intercellular adhesion molecule-1 (ICAM-1) and whether this expression is modulated by inflammatory cytokines. The researchers focused on determining if RPE ICAM-1 functions as a receptor for leukocyte adhesion. The motivation stemmed from the need to understand how RPE cells might regulate immune cell access to the retina during inflammatory conditions. The study also aimed to assess whether ICAM-1 on RPE cells could be upregulated by cytokines like interferon-gamma, interleukin-1 beta, and tumor necrosis factor-alpha. The goal was to establish a functional link between RPE ICAM-1 and leukocyte binding. The research sought to clarify the role of RPE ICAM-1 in immune responses at the blood-retina barrier. No prior work had directly examined the functional role of RPE ICAM-1 in this context. The study aimed to provide a mechanistic understanding of how RPE cells may contribute to immune regulation in the eye.
Main Methods:
The researchers used specific monoclonal antibodies to detect ICAM-1 on human RPE cells. Immunohistochemical staining was performed on freshly isolated and cultured RPE cells. The cells were exposed to recombinant interferon-gamma, interleukin-1 beta, and tumor necrosis factor-alpha. Fluorescence-activated cell sorting (FACS) was employed to quantify changes in ICAM-1 expression. Leukocyte adherence assays were conducted to assess the binding of neutrophils to RPE cells. Monoclonal antibodies targeting ICAM-1 or leukocyte receptors were used to block adhesion. Fresh uveoretinal explants were also exposed to cytokines and analyzed for ICAM-1 immunoreactivity. The study combined in vitro cell culture with ex vivo tissue analysis to assess ICAM-1 expression and function.
Main Results:
Freshly isolated and cultured RPE cells showed low baseline ICAM-1 expression. Exposure to interferon-gamma, interleukin-1 beta, or tumor necrosis factor-alpha increased ICAM-1 expression by up to two-fold within six hours. Fluorescence-activated cell sorting confirmed a significant increase in ICAM-1 levels after cytokine stimulation. Leukocyte adherence assays revealed that RPE cells bound neutrophils more strongly after cytokine exposure. Blocking ICAM-1 or leukocyte receptors significantly reduced adhesion in both unstimulated and stimulated RPE cells. Uveoretinal explants showed increased ICAM-1 immunoreactivity after cytokine treatment. The results suggest that RPE ICAM-1 is upregulated by inflammatory signals. The findings indicate that RPE ICAM-1 functions as a receptor for leukocyte binding.
Conclusions:
The study found that RPE cells express ICAM-1 at low levels under baseline conditions. The authors propose that ICAM-1 expression on RPE cells can be augmented by inflammatory cytokines. The results suggest that RPE ICAM-1 functions as a receptor mediating leukocyte adhesion. The findings indicate that RPE ICAM-1 may regulate immune cell infiltration in ocular diseases. The study supports the hypothesis that RPE ICAM-1 contributes to immune responses at the blood-retina barrier. The authors suggest that RPE ICAM-1 may be important in diseases where leukocytes play a pathogenic role. The results do not suggest that ICAM-1 is essential for all immune responses. The study does not propose that RPE ICAM-1 is the sole mediator of leukocyte binding.
Frequently Asked Questions
ICAM-1 on RPE cells is a functional receptor that mediates leukocyte adhesion, especially after stimulation with inflammatory cytokines like interferon-gamma.
ICAM-1 expression was measured using immunohistochemical staining and fluorescence-activated cell sorting (FACS) after exposing RPE cells to cytokines.
Interferon-gamma is a known inflammatory cytokine that upregulates ICAM-1 expression, making it a useful tool to assess RPE cell response to immune signals.
Blocking ICAM-1 or leukocyte receptors significantly reduced leukocyte binding to RPE cells, confirming the functional role of ICAM-1 in adhesion.
Cytokine stimulation increases ICAM-1 expression on RPE cells by up to two-fold within six hours, as shown by fluorescence-activated cell sorting analysis.
The study suggests that RPE ICAM-1 may regulate leukocyte infiltration in ocular diseases where immune cells contribute to pathology.